- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 14, 2025 | 41.68M sh |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $40.22M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $32.96M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $130.53M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $127.8M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $42.92M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $37.98M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $163.71M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $167.03M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $7.89M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2023 | $4.95M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 40M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 40M sh |
| Capex | Q2 2025 · Dec 31, 2023 | $2.95M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $3.49M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $32.38M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $28.16M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $25.31M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.09 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.16 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.09 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.16 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $2.92M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $4.83M |
| Net Income | Q2 2025 · Dec 31, 2023 | $3.74M |
| Net Income | Q2 2025 · Dec 31, 2023 | $6.5M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $4.76M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $8.08M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $7.68M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $12.9M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $34.33M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $70.35M |
| Revenue | Q2 2025 · Dec 31, 2023 | $42M |
| Revenue | Q2 2025 · Dec 31, 2023 | $83.25M |